Magnus Life Science

Magnus Life Science is a life sciences company based on ground-breaking clinical and academic research some of which originated from University College London.

The Company is developing treatments for a range of diseases based on a core understanding of blood flow. Magnus has secured £15.5m in private equity funding. Two programmes are further supported by €11.5m in EC FP7 grants.